HM2014-24: AN OPEN-LABEL PHASE 2 PROSPECTIVE,RANDOMIZED,

  • Ustun, Celalettin (PI)

Project: Research project

Project Details

Description

HM2014-24: AN OPEN-LABEL PHASE 2 PROSPECTIVE,RANDOMIZED, CONTROLLED STUDY OF CLT-008 MYELOID PROGENITOR CELLS AS A SUPPORTIVE CARE MEASURE DURING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA
StatusFinished
Effective start/end date4/21/1512/31/18

Funding

  • CELLERANT THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.